Clinical trials in T1D using colony-stimulating factor focused mainly on G-CSF, based on findings that G-CSF prevents diabetes in NOD mice by recruiting pDCs and functional CD4+CD25+Tregs. The gene discussed is CSF3; the disease is type 1 diabetes mellitus.